The historical overview by Dr de Craen and colleagues (October 1999 JRSM, pp. 511±515) raises many interesting questions, not least whether there could be a therapeutic role for placebo outside clinical trials. In common with many other orthodox accounts of medical history, however, the review disregards salient information from unorthodox sources. I have undertaken a comprehensive literature review of 19th-century homoeopathic placebo research and everyday usage to clarify current beliefs and open up new areas for debate 1 .
The earliest mention of noceboÐin Hahn's sense of patient expectations producing adverse effects from placebo 2 came as early as 1810 3 . Hahnemann had given placebo for a few days at the beginning of a course of treatment in chronic and non-urgent cases, before prescribing homoeopathically. Although this was initially as a washout for patients taking allopathic medication, he increasingly used placebo to derive psychological information about his patients. For instance, he states that hypersensitive patients who experience adverse effects from placebo are in fact revealing an important aspect of their conditionÐwhich has to be included when matching the`totality of symptoms' to the materia medica.
Public discussion of this ®rst seems to have occurred at the 1832 homoeopathic congress in Leipzig. The question was raised whether lactose placebos, commonly used in homoeopathy because indistinguishable from verum, could be intrinsically (i.e. chemically) harmful. The ensuing debate in the homoeopathic press makes it clear that nocebo effects were well known to homoeopaths at that time. Although it was felt that some cases could be attributed to carry-over effects of previously taken medicines and others to the natural course of disease, the general conclusion seems to have been that the patient's imagination was usually responsible 4 .
If it is believed that recognition of pathophysiological responses to placebo could scarcely have been possible at a time when failure to bleed, cauterize and mercurialize were punishable offences in some quarters, the historical record now clearly suggests otherwise. However improbable it may seem, given their reputation as quacks, early homoeopaths regularly compared their medicines with a control treatment in everyday practice. This casts an intriguing light on a therapy which many doctors and scientists still feel able to dismiss as a placebo, in the face of meta-analyses of randomized placebo-controlled trials which demonstrate homoeopathy's superiority. 5 Author's reply
The gas ®re was the presumed source of carbon monoxide although without a full inspection of the patient's house we cannot exclude another source such as a boiler. The ®re was reported as unlit but may have been releasing carbon monoxide while lit; the patient's carboxyhaemoglobin was very high.
Management of acute bursitis
In his useful paper (October 1999 JRSM, pp. 516±521) Dr Stell reports good results from initial aspiration. Since all 47 cases were aspirated it is not possible to say whether the expectant treatment with antibiotics commonly given in general practice is as good. In my experience, most settled well without aspiration or any surgical intervention.
Another study is needed to decide this and to see whether complications, such as occasional massive oedema of the forearm, are more common with or without aspiration. Having regard to his manifesto could he say that NICE and other bodies will not be used to justify a refusal to fund treatment that a specialist has judged would be of bene®t to a patient or to delay treatment that a specialist is satis®ed is appropriate for his or her patient'? This has not been addressed. I have now learned that the decision on beta-interferon is likely to be delayed another eight or nine months. We need someone like Dr Ellis behind usÐMS sufferers and their carers are just getting nowhere.
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